Cannara Biotech Inc. EBITDA for the year ending August 31, 2024: USD 11.24 M

Cannara Biotech Inc. EBITDA is USD 11.24 M for the year ending August 31, 2024, a -3.67% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Cannara Biotech Inc. EBITDA for the year ending August 31, 2023 was USD 11.67 M, a 60.67% change year over year.
  • Cannara Biotech Inc. EBITDA for the year ending August 31, 2022 was USD 7.26 M, a 184.18% change year over year.
  • Cannara Biotech Inc. EBITDA for the year ending August 31, 2021 was USD 2.56 M, a -136.46% change year over year.
  • Cannara Biotech Inc. EBITDA for the year ending August 31, 2020 was USD -7.01 M, a -13.82% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)